LivaNova (LIVN) Cash & Equivalents (2014 - 2026)

LivaNova has disclosed Cash & Equivalents across 13 years of filings, most recently posting $539.7 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $539.7 million, down 26.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $539.7 million (down 26.91% YoY), and the FY2025 annual result was $635.6 million, up 48.2% from the prior year.
• Cash & Equivalents came in at $539.7 million for Q1 2026 at LivaNova, down from $635.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $738.4 million in Q1 2025 to a low of $222.9 million in Q2 2023.
• The 5-year median for Cash & Equivalents is $311.4 million (2022), against an average of $386.2 million.
• Across the five-year window, Cash & Equivalents surged 138.82% in 2025 and decreased 26.91% in 2026, its largest moves.
• LivaNova's Cash & Equivalents stood at $301.4 million in 2022, then slipped by 11.59% to $266.5 million in 2023, then soared by 60.92% to $428.9 million in 2024, then soared by 48.2% to $635.6 million in 2025, then declined by 15.08% to $539.7 million in 2026.
• The last three Cash & Equivalents figures came in at $539.7 million (Q1 2026), $635.6 million (Q4 2025), and $593.6 million (Q2 2025), per Business Quant data.